<DOC>
	<DOCNO>NCT02866032</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy topical MOB015B patient mild moderate distal subungual onychomycosis ( DSO ) . The secondary objective evaluate safety topical MOB015B patient mild moderate DSO .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Topical MOB015B Treatment Mild Moderate Distal Subungual Onychomycosis ( DSO )</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Ciclopirox</mesh_term>
	<criteria>1 . Males females 18 70 year age 2 . Distal subungual onychomycosis ( DSO ) least one great toenail ( ) affect 20 % 50 % target nail 3 . Positive culture dermatophytes 4 . Signed write informed consent 1 . Proximal subungual onychomycosis 2 . Distal subungual onychomycosis great toenails involvement extend proximal portion target nail ( unaffected proximal nail le 3 mm ) 3 . Target toenail thickness 3 mm 4 . `` Spike '' onychomycosis extend eponychium target toenail 5 . Presence dermatophytoma ( define thick mass fungal hyphae necrotic keratin nail plate nail bed ) target nail 6 . Other condition DSO know cause abnormal nail appearance 7 . Presence toenail infection dermatophytes 8 . Previous target toenail surgery residual disfigurement 9 . Topical treatment nail antifungal medication medical device within 1 month Baseline/Visit 2 10 . Systemic use antifungal treatment within 7 month Baseline/ Visit 2 11 . Severe moccasin tinea pedis 12 . Signs severe peripheral circulatory insufficiency 13 . Uncontrolled diabetes mellitus 14 . Known immunodeficiency 15 . Participation another clinical trial investigational drug device previous 3 month Baseline/ Visit 2 16 . Known allergy test treatment product 17 . A positive pregnancy test indicate pregnancy woman childbearing potential Baseline/ Visit 2 18 . Females pregnant breastfeed 19 . Premenopausal ( last menstruation â‰¤ 1 year prior screen ) sexually active woman childbearing potential practicing acceptable method birth control , plan continue practice acceptable method birth control throughout trial 20 . Patients previously randomize study 21 . History , current drug alcohol abuse 22 . Psychiatric condition might limit participation study and/or lead assumption patient 's ability completely understand consequence consent miss 23 . Close affiliation investigator ( e.g . close relative ) person work study site , patient employee sponsor 's company 24 . Patients institutionalized legal regulatory order 25 . Any disease circumstance patient participate study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>